Merck and Mayo Clinic team up on AI-driven drug discovery
The partnership will allow the drug company new access to key data.
Evolution of AI in drug discovery within the healthcare landscape, featuring sharp analysis and essential updates on the latest industry news.
The partnership will allow the drug company new access to key data.
It’s one of a growing number of pharma-tech partnerships.
Generative AI is helping researchers discover medicine faster and has the potential to fill recruitment gaps for clinical trials.
One report found that AI could decrease the cost of discovering a new drug by as much as 70%. It currently takes about $2.8 billion to bring one drug to market.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.